Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How effective is sibutramine for the treatment of overweight adolescents?

Nature Clinical Practice Endocrinology & Metabolism volume 3, pages 82–83 (2007)Cite this article

boxed-textBerkowitz RI et al. (2006) Effects of sibutramine treatment in obese adolescents. Ann Intern Med 145: 81–90

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ogden CL et al. (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295: 1549–1555

    Article  CAS  Google Scholar 

  2. Robinson TN (1999) Behavioural treatment of childhood and adolescent obesity. Int J Obes Relat Metab Disord 23 (Suppl 2): S52–S57

    Article  Google Scholar 

  3. Yanovski JA (2001) Intensive therapies for pediatric obesity. Pediatr Clin North Am 48: 1041–1053

    Article  CAS  Google Scholar 

  4. Chanoine JP et al. (2005) Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 293: 2873–2883

    Article  CAS  Google Scholar 

  5. Bray GA (2004) Obesity is a chronic, relapsing neurochemical disease. Int J Obes Relat Metab Disord 28: 34–38

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice. JA Yanovski is supported by the Intramural Research Program of the NIH, grant ZO1-HD-00641 (National Institute of Child Health and Human Development). The author acknowledges that the views expressed in the Commentary represent his own opinions and should not be construed as representing those of the NIH or the US Public Health Service.

Author information

Author notes

  1. Unit on Growth and Obesity, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, NIH, Hatfield Clinical Research Center, Room 1E-3330, 10 Center Drive, MSC-1103, Bethesda, MD 20892-1103, USA jy15i@nih.gov

Authors and Affiliations

  1. JA Yanovski is the Head of the Unit on Growth and Obesity, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA.,

    Jack A Yanovski

Authors
  1. Jack A Yanovski
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

JA Yanovski is the principal investigator of a study using the weight-loss medication, orlistat, supplied by Roche under a materials transfer agreement with the NIH. Dr Yanovski receives no financial compensation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yanovski, J. How effective is sibutramine for the treatment of overweight adolescents?. Nat Rev Endocrinol 3, 82–83 (2007). https://doi.org/10.1038/ncpendmet0390

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0390

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing